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Abstract
Advanced age and mutations in the genes encoding amyloid precursor protein (APP) and presenilin (PS1) are two serious
risk factors for Alzheimer’s disease (AD). Finding common pathogenic changes originating from these risks may lead to a
new therapeutic strategy. We observed a decline in memory performance and reduction in hippocampal long-term
potentiation (LTP) in both mature adult (9–15 months) transgenic APP/PS1 mice and old (19–25 months) non-transgenic
(nonTg) mice. By contrast, in the presence of bicuculline, a GABAA receptor antagonist, LTP in adult APP/PS1 mice and old
nonTg mice was larger than that in adult nonTg mice. The increased LTP levels in bicuculline-treated slices suggested that
GABAA receptor-mediated inhibition in adult APP/PS1 and old nonTg mice was upregulated. Assuming that enhanced
inhibition of LTP mediates memory decline in APP/PS1 mice, we rescued memory deficits in adult APP/PS1 mice by treating
them with another GABAA receptor antagonist, picrotoxin (PTX), at a non-epileptic dose for 10 days. Among the saline
vehicle-treated groups, substantially higher levels of synaptic proteins such as GABAA receptor a1 subunit, PSD95, and NR2B
were observed in APP/PS1 mice than in nonTg control mice. This difference was insignificant among PTX-treated groups,
suggesting that memory decline in APP/PS1 mice may result from changes in synaptic protein levels through homeostatic
mechanisms. Several independent studies reported previously in aged rodents both an increased level of GABAA receptor
a1 subunit and improvement of cognitive functions by long term GABAA receptor antagonist treatment. Therefore, reduced
LTP linked to enhanced GABAA receptor-mediated inhibition may be triggered by aging and may be accelerated by familial
AD-linked gene products like Ab and mutant PS1, leading to cognitive decline that is pharmacologically treatable at least at
this stage of disease progression in mice.
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Introduction
Both aging and mutations in genes that encode amyloid
precursor protein (APP) and presenilin (PS) are considered to be
major risk factors for Alzheimer’s disease (AD). Aß that is
generated from APP, partly through the proteolytic action of
PS1 complex, oligomerizes and causes neurotoxicity via synaptic
dysfunction [1–3]; and the appearance of Aß oligomers correlates
with the initiation of memory impairment in a mouse model of AD
[4]. On average, cognitive abilities decline with age, yet a
recognizable subpopulation of older individuals maintains mental
abilities [5]. Both aging and gene risks are known to be tightly
associated with glutamate excitotoxicity via calcium dysregulation
[6–8]. On the other hand, the complex symptoms of AD and their
partial correlation with pathological hallmarks indicate that
understanding the pathogenesis of AD may require investigations
of abnormalities at multiple levels; this would enhance our
awareness that various compensatory mechanisms are at work in
maintaining brain functions [9]. It is desirable to find a way to
improve memory based on the common mechanisms responsible
for cognitive decline due to aging (i.e., non-genetic) and genetic
risks. In the present study, we investigated spatial memory
performance and hippocampal long-term potentiation (LTP) in
relatively young but mature ‘‘adult’’ (9–15 months) and aged or
‘‘old’’ (19–25 months) non-transgenic (nonTg) mice and in adult
APPswe/PS1Dexon9 (APP/PS1) transgenic mice [10]. On the
basis of changes we observed in memory performance and LTP
linked with enhanced GABAA receptor-mediated inhibition, we
tested the effects of picrotoxin (PTX), a GABAA receptor
antagonist and observed that 10 days of PTX treatment improves
the cognitive functions of adult APP/PS1 mice.
Results
Cognitive decline in adult APP/PS1 mice
The Morris water maze (MWM) test was administered as
described in the Materials and Methods. Three groups of male
mice from the same line were tested: adult nonTg, adult APP/PS1,
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spatial memory task leads to incremental learning of a constant
platform location, and by the 10th day, formation of long-lasting
spatial reference memory is clearly manifested [11]. Consistent
with previous observations [12–14], during the acquisition phase
adult APP/PS1 mice took longer to reach the hidden platform
than did adult nonTg littermate control mice (F[1,25]=17.95,
p=0.0003; repeated measures two-way ANOVA) (Figure 1A).
Such a substantial delay in learning was not observed in old nonTg
mice. These results were recapitulated by two other measures,
namely, distance (F[1,25]=11.69, p=0.0022) and error score
(F[1,25]=11.79, p=0.0021) (Figure 1B and 1C). Distance is the
path-length that a mouse swims during each trial. The error score
is similar to ‘‘search error’’ or ‘‘behavioral index,’’ two parameters
described previously [5,15]. The error score was calculated by
integrating the distances between the mouse and platform every
0.5 sec in each trial. The swimming speed did not differ
significantly among the three groups (Figure 1D). For the probe
tests on the 10th day, the percentage of dwell time spent in the
target quadrant was calculated (Figure 1E). Adult nonTg mice had
a significant place preference for the target quadrant according to
the Friedman test (p=0.0001). Although adult APP/PS1 mice
showed a place preference in the first probe trial (p=0.0066;
Friedman test), by the second probe trial they were clearly
searching randomly, since they did not exceed 25% dwell time in
the target quadrant, suggesting that even any place preference
they acquired quickly became extinct. Old nonTg mice used in
this MWM test were wild-type controls from the same lines as the
adult nonTg and adult APP/PS1 mice. Statistically, this small
cohort from a single line did not show a place preference for the
target quadrant during the first probe trial. By repeating the probe
test four times, we observed that adult nonTg mice spent more
time in the target quadrant than either adult APP/PS1
(F[1,25]=11.39, p=0.0024; repeated measures two-way AN-
OVA) or old nonTg mice (F[1,19]=4.56, p=0.0459; repeated
measures two-way ANOVA). There was also a significant
difference among the three groups according to the first trial’s
probe score (p=0.0094; Kruskal-Wallis test), that is, the probe test
version of the error score divided by the total number of recorded
frames (a frame/0.5 sec660 sec=120 frames). A direct compar-
ison also showed a significant difference between adult nonTg and
adult APP/PS1 mice (**p=0.0033; two-tailed Mann-Whitney U
test), indicating that the memory of adult APP/PS1 mice was less
accurate, since higher probe scores mean that a mouse was
swimming in an area distant from the target (i.e., the center of the
position where the platform was located during the acquisition
period). These results suggest that some of the cognitive functions
in APP/PS1 mice decline during adulthood.
Age-related cognitive decline in wild-type mice
Cognitiveabilitiesareknowntodecline,onaverage,withageeven
though a subpopulation of older individuals maintains mental
abilities [5]. Thus, we hypothesized that a greater number of mice
might show an age-dependent change in cognitive function. Because
only a limited number of animals, especially aged ones, were
available from a single line, we examined 100 wild-type control mice
(58 adult and 42 old) from multiple transgenic lines having in
common the C57BL/6J background strain. In contrast to adult
nonTg mice, old nonTg mice showed delayed learning performance
in terms of latency (F[1,98]=5.74, p=0.0167; repeated measures
two-way ANOVA) and error score score (F[1,98]=11.42,
p=0.0008; repeated measures two-way ANOVA) [5,15], but not
in terms of distance (Figure 2A, 2B, and 2C). Swimming speed was
not statistically different between adult and old nonTg mice
(Figure 2D). Both nonTg mouse groups formed a place preference
for the target quadrant in the probe test (both age groups,
*p,0.0001; Friedman test) (Figure 2E). However, the probe score
of old nonTg mice was significantly higher than that of adult nonTg
mice (**p=0.0038; two-tailed Mann-Whitney U test) (Figure 2F).
This result suggests that aged animals memorized the target position
less accurately than younger ones. We also analyzed each age group
to determine whether the accuracy of memory was age-dependent
(Figure 2G). As the trend line indicates in Figure 2G, a significant
correlation between age and probe score was observed only in the
old nonTg group (p=0.0455; two-tailed Spearman test), supporting
the hypothesis that an age-dependent reduction in the accuracy of
memory becomes more prominent in older individuals. We also
detected a differenceinthe distribution pattern ofthe probe scores of
adult and old nonTg mice (p=0.0095; two-sample Kolmogorov-
Smirnov test) (Figure 2H). Whether such a difference in the
distribution of a cognitive function also exists inAPP/PS1 transgenic
mice may be revealed in the future by examining a greater number
of animals. The present results suggest that at least, on average, slow
learning and inaccurate memory are common features of cognitive
decline in adult APP/PS1 mice and old nonTg mice.
LTP reduction is linked to upregulated inhibition via
GABAA receptors in adult APP/PS1 and old nonTg mice
To understand how aging-associated memory decline and
memory decline associated with mutant APP/PS1 genes might be
linked with changes in the plasticity of synapses, we next measured
LTP in the dentate gyrus region of hippocampal slices. In vitro
slices were prepared from the same three groups of mice. Tetanic
stimulation was used to elicit LTP by activating NMDA receptors,
thus engaging calcium-dependent processes [16]. Slices from adult
APP/PS1 mice and old nonTg mice showed significantly less
tetanus-induced LTP compared to slices from adult nonTg mice
(Figure 3A and 3B). These results are consistent with results from
the MWM tests (Figure 1 and 2), which showed a decline in the
cognitive performance of adult APP/PS1 and old nonTg mice.
Deficits in synaptic plasticity have been identified in aged
animals with cognitive impairment [17]. Other studies using
rodents have also shown that the amount of GABAA receptors
increases in the hippocampus with aging [18–21]. Therefore, we
hypothesized that reduced LTP in slices from old nonTg mice may
be related to enhanced inhibition resulting from an increased
number of GABAA receptors. To estimate the degree of LTP
reduction via GABAA receptors, we measured LTP in the
presence of bicuculline, a GABAA receptor antagonist (Figure 3A
and 3B). Under this condition, LTP in slices from both old nonTg
mice and adult APP/PS1 mice was enhanced compared to LTP in
slices from adult nonTg mice. A greater magnitude of LTP in the
presence of bicuculline indicated that synaptic inhibition mediated
by GABAA receptors in adult APP/PS1 and old nonTg mice was
upregulated, perhaps as a possible compensatory response to
increased synaptic excitation (Figure 3B, 3C and 3D). Thus, adult
APP/PS1 mice and old nonTg mice shared the following
characteristics: upregulated GABAA receptor-mediated inhibition
linked to LTP reduction and memory decline. Assuming that
upregulation of GABAA receptor-mediated inhibition, which
usually occurs with aging, was accelerated in APP/PS1 mice, we
next examined whether a treatment aimed at normalizing
inhibition might improve memory in adult APP/PS1 mice.
PTX treatment improves memory in adult APP/PS1 mice
Excessive GABA-mediated inhibition was reported in the
Ts65Dn mouse model of Down syndrome (DS), which expresses
three copies of chromosome 16 genes like APP, GluR5, etc. [22].
GABAA-Linked Memory Decline
PLoS ONE | www.plosone.org 2 August 2008 | Volume 3 | Issue 8 | e3029Figure 1. Memory decline in adult APP/PS1 mice in the MWM. (A) Adult APP/PS1 mice, but not old nonTg mice, took significantly longer than
adult nonTg mice to reach the hidden platform over the 9-day task acquisition period (F[1,25]=17.95, p=0.0003, repeated measures two-way
ANOVA). Differences between adult nonTg and adult APP/PS1 mice was also observed in both the distance or the path-length that the mouse swam
(F[1,25]=11.69, p=0.0022) (B) and in the error score (F[1,25]=11.79, p=0.0021), which is defined in the Materials and Methods (C). (D) In terms of
swimming speed, no statistical difference was detected among the three groups. (E) Four post-acquisition probe trials were run, and the average
GABAA-Linked Memory Decline
PLoS ONE | www.plosone.org 3 August 2008 | Volume 3 | Issue 8 | e3029It has also been reported that chronic treatment of Ts65Dn mice
with the non-competitive GABAA receptor antagonist PTX ‘‘at a
non-epileptic dose’’ improves Ts65Dn object recognition memory
[23]. AD and DS share many common features, and all
individuals with DS develop the neuropathology of AD [24].
Since we observed enhanced inhibition in adult APP/PS1 mice,
we hypothesized that PTX treatment might also improve memory
in this mouse model of AD. Adult APP/PS1 and adult nonTg
mice were given daily injections of PTX (1.0 mg/kg in a volume of
10.0 ml/kg) or saline vehicle intraperitoreally in their home cages
for 10 days. Then, four groups of adult male mice (saline-treated
nonTg, saline-treated APP/PS1, PTX-treated nonTg, and PTX-
treated APP/PS1) were tested on a novel object recognition
(NOR) task capable of detecting hippocampal and parahippo-
campal dysfunction in declarative memory processing [23]. After
being habituated in a new cage, each mouse was exposed to two
identical objects placed in two corners of the apparatus during a
15-min training session (Figure S1). As expected, the four groups
of mice explored the two identical objects to the same extent
(Figure 4A). After the training session, a 15-min testing session was
conducted by replacing one of the familiar objects with a novel
object (Figure 4B). Binomial analysis showed that nonTg and
PTX-treated APP/PS1 mice preferentially explored the novel
object (Figure 4B). In contrast, the group of saline-treated APP/
PS1 mice explored novel and familiar objects to the same extent or
indiscriminately (Figure 4B). Taken together, these results showed
that PTX treatment partially rescued object recognition memory
in adult APP/PS1 mice.
Four groups of mice (saline-treated nonTg, saline-treated APP/
PS1, PTX-treated nonTg, and PTX-treated APP/PS1) were also
tested on the MWM test. Here, we used error score as a measure
of learning performance [5,15]. Saline-treated APP/PS1 mice
showed a significantly higher error score than saline-treated
nonTg mice (F[1,10]=13.73, p=0.0041; repeated measures two-
way ANOVA), indicating impaired spatial learning in saline-
treated APP/PS1 mice (Figure 4C). When the mice were treated
with PTX, no significant difference was observed between the two
genotypes (Figure 4D). This result suggests that adult APP/PS1
and adult nonTg mice have similar learning abilities as a result of
the PTX treatment. The improvement of learning was directly
reflected in their place preference in the probe test (Figure 4E and
4F). Saline-treated APP/PS1 mice searched each quadrant
randomly (p=0.772; Friedman test). The cognitive performance
of saline-treated APP/PS1 mice was unlike that of untreated adult
APP/PS1 mice, which exhibited a small but significant place
preference for the target quadrant (Figure 1E and 4F). We
assumed that the complete loss of spatial reference memory in
saline-treated APP/PS1 mice was due to stress induced by the
daily intraperitoreal injections they received for 10 days. Indeed,
the cognitive function of another AD mouse model (APPV717I-
CT100) has been previously reported to be especially vulnerable to
chronic stress [25]. Since it is now widely accepted that an
enriched environment improves cognitive function of some
transgenic mice, including APP/PS1 [26,27], it is expected that
a poor environment, such as stress from daily injections, would
have an opposite effect, causing cognitive function to decline. Most
notably, even under these stressful conditions, PTX-treated APP/
PS1 mice preferentially searched the target quadrant (p=0.0057;
Friedman test) (Figure 4F). In fact, PTX treatment substantially
raised place preference in adult APP/PS1 mice up to the level of
adult nonTg mice (Figure 4E and 4F). These results suggested that
spatial reference memory in adult APP/PS1 mice was rescued by
the 10-day PTX treatment.
Modification of synaptic protein levels by 10-day PTX
treatment
We were next interested in determining at the protein level how
the memory deficits in APP/PS1 mice that are linked to enhanced
GABAA receptor-mediated inhibition were improved by PTX
treatment. The amount of GABAA receptor a1 subunit in
membrane fractions derived from brain homogenates of mice in
drug-treatment experiments (Figure 4) was assessed by Western blot.
Saline-treated APP/PS1 mice showed stronger GABAA a1i m m u -
noreactivity than saline-treated nonTg mice (Figure 5A). This
difference between APP/PS1 and nonTg mice was absent when the
mice received PTX treatments (Figure 5A and 5B). These results
suggest that enhanced GABAA receptor-mediated inhibition and its
associated memory decline in adult APP/PS1 mice might be due to
an elevated amount of GABAA receptor a1 subunit, which has also
been reported in aged rat hippocampus [18–21].
To investigate what might have caused the increased GABAA
receptor-mediated inhibition in adult APP/PS1 mice, we further
examined changes in the levels of other proteins involved in
synaptic plasticity (Figure 5C). Because the immunoreactivity of
some antibodies on these samples was somewhat variable, we
calculated the averages of immunofluorescent intensities from
three blots by normalizing band intensities with those obtained
from samples of saline-treated nonTg mice in each blot. Among
the five antibodies that we tested, immunoreactivity against
PSD95 and NR2B were significantly stronger for samples from
saline-treated APP/PS1 mice compared to those from saline-
treated nonTg mice (Figure 5D). Because the phosphorylation of
NR2B at Tyr1472 stabilizes NMDA receptors on the cell surface
[28], making them functionally active, we also tested an antibody
against Tyr1472-phosphorylated NR2B (p-NR2B). There was no
significant difference among the groups. As a result, the ratio of the
relative immunoreactivity of p-NR2B to total NR2B was lower in
APP/PS1 mice compared to nonTg mice. As with the case of the
GABAA receptor a1 subunit, these differences between APP/PS1
and nonTg mice in the levels of PSD95 and p-NR2B/NR2B also
diminished upon PTX treatment through yet unknown mecha-
nisms. Because a statistically significant difference in the levels of
PSD95 and GABAA receptor a1 was not detected between saline-
and PTX-treated APP/PS1 mice, the comparable levels of these
proteins in nonTg and APP/PS1 mice after PTX treatment
indicate that there might be some insignificant increase in these
proteins in PTX-treated nonTg mice. In the case of NR2B, there
was a significant decrease in APP/PS1 mice by PTX treatment in
comparison with saline treatment (*p=0.0383; two-tailed Stu-
dent’s t-test and *p=0.0499; repeated measures two-way
ANOVA), while there was no increase in nonTg mice. Together
percentage of time spent in the target quadrant was plotted. Repeated measures two-way ANOVA analysis showed that adult nonTg mice spent a
greater percentage of time searching the target quadrant than adult APP/PS1 mice (F[1,25]=11.39, p=0.0024) and old nonTg mice (F[1,19]=4.56,
p=0.0459). The gray horizontal line in (E) represents random search. (F) The probe scores of adult APP/PS1 mice were significantly higher than those
of adult nonTg mice (**p=0.0033; two-tailed Mann-Whitney U test), suggesting that adult APP/PS1 mice have reduced memory accuracy. The
number of mice tested was 13 adult nonTg (9–13 months, 11.061.4 months), 14 adult APP/PS1 (9–13 months, 11.061.5 months), and 8 old nonTg
mice (19–21 months, 20.361.2 months). The nonTg mice used in these experiments were wild-type littermates and controls of the single APP/PS1
transgenic line.
doi:10.1371/journal.pone.0003029.g001
GABAA-Linked Memory Decline
PLoS ONE | www.plosone.org 4 August 2008 | Volume 3 | Issue 8 | e3029Figure 2. Age-dependent delay in learning and reduced accuracy of memory in wild-type mice. (A) Old nonTg mice took significantly
longer than adult nonTg mice to reach the hidden platform (F[1,98]=5.74, p=0.0167; repeated measures two-way ANOVA). (B) There was no
statistical difference in the distances swam by mice of the two age groups. (C) The error scores of old nonTg mice were significantly higher than those
of adult nonTg mice (F[1,98]=11.42, p=0.0008; repeated measures two-way ANOVA). (D) The swimming speed of mice of the two age groups was
not significantly different. (E) Both adult and old nonTg mice displayed a place preference for the target quadrant in the probe test (both age groups,
*p,0.0001; Friedman test). There was no statistical difference in the percentage dwell time in the target quadrant of adult and old nonTg mice. (F)
GABAA-Linked Memory Decline
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mice expressed greater LTP than adult nonTg mice after blocking
GABAA receptor-mediated inhibition, the abnormally high levels
of PSD95 and NR2B potentially indicate that synaptic excitation
in adult APP/PS1 mice is overly enhanced, which in turn could
lead to a compensatory upregulation of GABAA receptor-
mediated inhibition through the activation of homeostatic
mechanisms. Although we still do not know exactly how this
excitation/inhibition abnormality was created in APP/PS1 mice,
their memory deficits, which were linked with a reduction in LTP
and induced by enhanced GABAA receptor-mediated inhibition,
were improved by PTX treatment, presumably through modifying
the levels of proteins involved in synaptic plasticity.
Discussion
Memory decline in both adult APP/PS1 and old nonTg mice
was commonly accompanied by reduced LTP expression that was
linked with excessive inhibition via GABAA receptors. On the basis
of these findings, we hypothesized that memory decline associated
However, the probe scores of the old nonTg mice were significantly higher than those of adult nonTg mice (**p=0.0038; two-tailed Mann-Whitney U
test), indicating that the memory of old nonTg mice was less accurate than that of adult nonTg mice. In terms of both percentage of target-quadrant
dwell time and probe score, there was no significant difference between the small cohorts of nonTg mice from the single mouse line used in
experiments for Figure 1 and the large cohorts from multiple lines used here at each age group. A significant difference in probe score between the
large cohort of adult nonTg mice (n=58) and the small cohort of adult APP/PS1 mice (n=14) was ascertained (p=0.0059; two-tailed Mann-Whitney U
test). (G) There was a significant correlation between age and probe score within the old nonTg mouse group (p=0.0455; two-tailed Spearman test)
but not within the adult nonTg mouse group. No correlation was observed among the adult APP/PS1 mice used for the experiments of Figure 1. (H)
In the cumulative probability plot, there was also a significant difference in the distribution of probe scores of nonTg mice for two age groups
(p=0.0095; two-sample Kolmogorov-Smirnov test). Mice used in these experiments were nonTg controls from a variety of transgenic lines with a
common C57BL/6J background strain. We used 58 adult mice (9–15 months, 11.761.6 months) and 42 old mice (19–25 months, 21.861.6 months).
doi:10.1371/journal.pone.0003029.g002
Figure 3. Enhanced GABAA receptor-mediated inhibition reduces LTP in adult APP/PS1 and old nonTg mice. (A) LTP in the molecular
layer of the dentate gyrus was recorded in the absence and presence of bicuculline to estimate the extent of GABAA receptor-mediated inhibition. In
aCSF-bathed slices, tetanus-induced LTP expression in adult APP/PS1 and old nonTg mice was smaller than that in slices from adult nonTg mice. In
contrast, in the presence of bicuculline, LTP in slices from adult APP/PS1 and old nonTg mice was larger than that in slices from adult nonTg mice. (B)
Data collected from the last 30 min in (A) were averaged. The means of the three groups in each condition with or without bicuculline showed
significant differences in the Friedman test (p,0.0001). However, the Dunn’s multiple comparison test (*p,0.001) showed a significant difference
between adult nonTg and adult APP/PS1 but not between adult nonTg and old nonTg in the presence of bicuculline. (C) The averaged data in the
condition without bicuculline was subtracted from the data in the condition with bicuculline, showing the higher extent of inhibition mediated by
GABAA receptors in adult APP/PS1 and old nonTg mice. (D) The values from the last 30 min in (C) were averaged; *p,0.0001; two-tailed Mann-
Whitney U test. The numbers of slices and mice used in each condition were as follows: bicuculline-treated slices–17 slices from 9 adult nonTg mice,
24 slices from 9 adult APP/PS1 mice, and 20 slices from 5 old nonTg mice; untreated slices–13 slices from 9 adult nonTg mice, 16 slices from 9 adult
APP/PS1 mice, and 22 slices from 5 old nonTg mice. The ages of mice were 9–11 months (9.360.7 months) for adult nonTg; 9–11 months (9.560.9
months) for adult APP/PS1; and 20–24 months (22.762.0 months) for old nonTg mice. The nonTg mice used for LTP measurements were nonTg
littermates and controls from a variety of transgenic lines, all having in common the C57BL/6J background strain.
doi:10.1371/journal.pone.0003029.g003
GABAA-Linked Memory Decline
PLoS ONE | www.plosone.org 6 August 2008 | Volume 3 | Issue 8 | e3029with aging was accelerated in APP/PS1 mice through enhanced
GABAA receptor-mediated inhibition resulting from the effects of
gene product(s) of early-onset AD such as Aß. In other words, Aß
may facilitate aging-associated memory decline through upregula-
tion of GABA-mediated inhibition, even though what mimics the
actions of Aß in aging remains to be determined.
A previous report suggested that aberrant excitation causes
compensatory enhancement of inhibition by circuit remodeling in
hAPP mice [29]. Similarly, in both adult APP/PS1 and old nonTg
mice, a greater increase in LTP expression due to the addition of
bicuculline compared to the lower increase in LTP in adult nonTg
mice suggests abnormal enhancement of both excitation and
inhibition. The difference in the efficacy of bicuculline on LTP
expression between hAPP and APP/PS1 mice may be attributed to
consequences relating to the PS1 mutant gene, because mutant PS1
single transgenic and knock-in mice have been reported to have
Figure 4. Memory facilitation in adult APP/PS1 mice treated with PTX. The effect of 10-day PTX treatment (at a non-epileptic dose) on short-
term object recognition memory was tested with a NOR task. Long-term spatial reference memory was tested with the MWM task. (A, B) Preference
indices (P. I.) during training (A) and testing (B) in the NOR task in PTX- and saline-treated nonTg and APP/PS1 mice (n=6 per group). Adult APP/PS1
mice showed partial recovery of object recognition memory with PTX treatment; *p=0.0161 and **p=0.000244, binomial analysis for accessing
novel objects. (C, D) Learning session error scores of saline-treated nonTg and APP/PS1 mice (C) and PTX-treated nonTg and APP/PS1 mice (D) tested
on the MWM task. In saline-treated groups, adult APP/PS1 mice showed spatial learning impairment (F[1,10]=13.73, p=0.0041; repeated measures
two-way ANOVA). In PTX-treated groups, there was no significant difference between APP/PS1 and nonTg mice (F[1,10]=3.08, p=0.1099; repeated
measures two-way ANOVA). (E, F) Performance during the probe trial showed significant improvement in PTX-treated APP/PS1 mice (preference in
target quadrant over other quadrants; p=0.0057; the Friedman test). The swimming traces of the mice are shown in blue. The target quadrant is
indicated by a circle, which represents the location of the platform during training; *p=0.0260; two-tailed Mann Whitney U test. The ages of mice
were 9–13 months (10.961.6 months) for nonTg saline; 9–10 months (9.960.1 months) for nonTg PTX; 9–13 months (11.161.7 months) for APP/PS1
saline; and 9–13 months (10.861.7 months) for APP/PS1 PTX mice. The nonTg mice used in the drug-treatment experiments were wild-type
littermates and controls of the APP/PS1 line.
doi:10.1371/journal.pone.0003029.g004
GABAA-Linked Memory Decline
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[30–34]. Several PS1 mutations are associated with enhanced
ryanodine receptor-mediated calcium release through increased
receptor expression [35]. Aß renders neurons more vulnerable to
excitotoxic insults through destabilization of calcium homeostasis
[7]. Increased levels of both PSD95 and NR2B in the brains of adult
APP/PS1 mice, whichmight be generated during homeostasis as Aß
downregulates PSD95 and NR2B [36,37], suggests that the synapses
of these mice have the potential to be overly excited. Aß oligomers
have also been suggested to form calcium channels by themselves
[38]. Excitotoxic insults caused by both excess glutamate release and
activation of glutamate receptors are also known to occur with aging
[6]. The density of voltage-gated calcium channels coupled with
potassium currents is known to increase with age [39]. PSD95 levels
are higher in learning-impaired aged rats than in unimpaired aged
rats [40]. Age-related increases in GABAA receptor levels has also
been reported in the hippocampus of rodents [18–21]. Although Aß,
mutant PS1, or aging can differentially trigger overexcitation, the
outcome (i.e., smaller LTP) of the compensatory upregulation of
GABAA receptor-mediated inhibition was commonly linked with
memory decline in mice.
We confirmed the reversibility of this abnormality by treating
adult APP/PS1 mice with a non-epileptic dose of PTX for 10 days.
Modifications of the amounts of GABAA a1, PSD95, and p-NR2B/
NR2B as well as cognitive functions caused by the PTX treatment
indicated that memory decline in adult APP/PS1 mice resulted, at
least in part, from changes in synaptic protein levels through
homeostatic mechanisms [41]. Since the protein levels were
examined only once after treatment, we could not determine
whether the alterations in protein levels were transitory or long-
lasting phenomena. This important issue is worth examining in the
near future. In the present experiments, the effects were detected in
the brains at least one month after the treatment. This is consistent
with the effects on the synaptic plasticity and cognitive functions of
Ts65Dn mice, a model of Down syndrome, which persisted for a few
months after similar treatment with GABAA receptor antagonists
[23].Althoughwedid not testhow PTXtreatmentaffectsoldnonTg
mice, long-term treatment of aged rats with subconvulsive doses of
pentylenetetrazole, another noncompetitive GABAA receptor an-
tagonist, also improves the cognitive functions of these rats [42],
lending support for a common GABAA receptor-mediated mecha-
nism underlying cognitive decline induced by aging and by FAD-
Figure 5. Modification of synaptic protein levels in adult APP/PS1 mice by PTX treatment. The effect of 10-day PTX treatment on the
protein level of GABAA receptor a1 subunit was examined by Western blot analysis of brain homogenates. (A, B) Immunoreactivity against the GABAA
receptor a1 subunit, as demonstrated by Western blotting, showed that the excess amount of this subunit in saline-treated APP/PS1 mice in
comparison with the amount in saline-treated nonTg mice was absent in PTX-treated animals; *p=0.0274, two-tailed Student’s t-test. (C, D) Western
blotting of membrane fractions from four groups of mice. Blots probed with antibodies against various receptors and PSD95 showed that the
amounts of PSD95 and NR2B, but not other proteins, were higher in APP/PS1 mice than in nonTg mice. Because p-NR2B (NR2B phosphorylated at
Tyr1472) did not differ among the four groups, the p-NR2B–to–total NR2B ratio in APP/PS1 mice was lower than that in nonTg mice. However, this
difference between saline-treated nonTg and APP/PS1 mice was diminished by PTX treatment. Saline-treated nonTg mice vs. APP/PS1 mice: PSD95,
*p=0.00873; NR2B, *p=0.00910; p-NR2B/NR2B, *p=0.00871; two-tailed Student’s t-test. Repeated measures two-way ANOVA also showed a
significant difference in NR2B levels (F[1,4]=14.32, *p=0.0194) but not in PSD95 levels (F[1,4]=5.27, p=0.0834). Saline-treated APP/PS1 mice vs. PTX-
treated APP/PS1 mice: NR2B, *p=0.0383; p-NR2B/NR2B, *p=0.0114; GABAA receptor a1 subunit, not significant p=0.0810; PSD95, not significant
p=0.4304; two-tailed Student’s t-test. Repeated measures two-way ANOVA also showed a significant difference in NR2B levels (F[1,4]=7.72,
*p=0.0499) but not in PSD95 levels (F[1,4]=0.31, p=0.6070).
doi:10.1371/journal.pone.0003029.g005
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progressive challenges and compensates them through the activation
of homeostatic mechanisms [43]. Here, we propose that upregulated
GABAA-receptor mediated inhibition underlies one of the homeo-
static mechanisms that are activated by various insults accumulating
in the brain during aging such as Aß and that over time compromise
synaptic plasticity, neural circuitry, and cognitive functions.
The purpose of PTX treatments in adult APP/PS1 mice was to
normalize GABAA receptor-mediated inhibition by maintaining
balance between inhibition and excitation to the extent of enhancing
LTP and memory. We certainly recognize the risk of excitotoxicity
via calcium overload [6–8,35,38,39,44] and that of epilepsy [29] if
GABA inhibition is overly and acutely inhibited. Simultaneously
targeting excitotoxic insults of various sources hopefully reduces
these risks and more directly prevents the initiation of excitation/
inhibition abnormalities, as clinically proven by the symptomatic
efficacies of a NMDA receptor antagonist on AD patients [45]. The
dose of PTX used in this study is non-convulsive but is known to
generate anxiety in conflict situations [46]. To see if such an
anxiogenic effect was produced in our PTX-treated mice, we
analyzed novel object exploration (NOE) from data collected during
the NOR experiments (Figure S1 and S2). In nonTg mice, PTX-
treated mice, on average, showed less preference for the ‘‘objects
field’’during the training session than during the habituation session,
whereas saline-treated nonTg mice showed more preference.
Avoidance of objects placed in a familiar field is considered to be a
measure of anxiety levels [47]. Thus, as expected from a known
anxiogenic effect of PTX treatment [46], this tendency indicates that
our PTX-treatment regimen may enhance anxiety levels in nonTg
mice even though we failed to find a statistical difference between
PTX- and saline- treated groups. This tendency was not even
observed in APP/PS1 mice. The question is whether enhanced
anxiety or fear can improve cognitive function in these mice. Our
results showed that PTX treatment did not change object
recognition memoryinnonTg micebutenhanced objectrecognition
memoryin APP/PS1mice(Figure4B).Thus,theresultsprovidedno
evidence to support the premise that anxiety alone promotes
cognitive function.Becausethe MWM test is itselfstressful to mice, it
is even more difficult to clearly determine to what extent drug
treatmentand stressresponseinfluencedemotionalfactors,including
anxiety, and to determine their impact on spatial reference memory.
Memory and emotion are inseparable and interdependent brain
functions [48]. Thus, improving one will directly affect, or be
affected by, the other, an observation that may point to an
alternative therapeutic approach for AD.
Materials and Methods
Animals
We used 9–15-month-old male hemizygous APP/PS1 mice
derived from a line that doubly expresses human APP carrying
Swedish familial AD-linked mutations (K670N/M671L) and
human PS1 encoding the exon 9 deletion mutation, each driven
by its own mouse prion protein promoter element [10]. Transgenic
(Tg) mice (B6C3-Tg(APP695)85Dbo Tg(PSEN1)85Dbo) were
originally purchased from the Jackson Laboratory. This transgenic
line had been crossed for 4–6 generations onto the C57BL/6J Jcl
(CLEA) background. All of the mice used in this study were males
of the C57BL/6J background strain. To examine age-related
changes in cognitive function and synaptic plasticity, we classified
mice as either ‘‘adult’’ (9–15 months) or ‘‘old’’ (19–25 months). The
number and age range (mean6S.D.) of mice used in each
experiment and whether wild-type controls were nonTg mice from
single or multiple transgenic lines are indicated in the figure
legends. All experiments were performed according to procedures
approved by the Animal Care and Use Committee of the Institute
of Physical and Chemical Research (RIKEN).
Morris water maze test
To assess place learning and memory performance of mice, we
used a cylindrical test apparatus (1 m in diameter) and task
fashioned after the Morris water maze. The water was maintained
at 24uC, and the maze was surrounded by landmark objects. A
slightly submerged transparent platform to which the mice could
escape was hidden from view by making the water opaque with a
white bio-safe material. The position of the platform was fixed
during a 60-sec test period.
Mouse behavior during the water maze test was monitored by a
CCD camera mounted overhead; digital data of real-time images
were recorded to a PC using the public domain NIH Image
program (developed at The National Institute of Mental Health
and available on the Internet at http://rsb.info.nih.gov/nih-
image/). Images were sampled at 2 Hz. Data was analyzed using
customized software based on Matlab (version 7.2, Mathworks Co.
Ltd., MA) with image analysis tool box (Mathworks Co. Ltd.).
During testing, the sequential position of the mouse was
determined in each video frame, and the swimming speed,
distance from platform, and latency to reach the platform were
calculated. To assess learning, for each mouse we measured the
distance between the mouse and the platform every 0.5 sec until
the mouse reached the platform. Then, we integrated these
distances between the mouse and the platform during each trial.
This ‘‘integrated distance’’ value represents the error score, which
is used here as a measure of learning performance [49]. The error
score was slightly modified from ‘‘search error’’ or ‘‘behavioral
index,’’ two parameters described previously [5,15]. To assess the
accuracy of memory, we also calculated the probe score by
dividing the error score derived during the probe test by the total
number of recorded frames (a frame/0.5 sec660 sec=120
frames).
For each learning trial, the mouse was gently placed on the
water surface close to the cylinder wall in each quadrant at
random (except the target quadrant where the platform was
located). The entry quadrant for each trial was always different
from that of the prior trial. The mouse was allowed to swim freely
for a 60-sec test period. When the mouse did not escape to the
submerged platform within this test period, we gently navigated it
to the platform by hand and made it stay there for 20 sec. For
each mouse, we carried out three learning trials per day for nine
successive days. Four probe trials were given on the tenth day, in
which the platform was removed from the maze in the mouse’s
absence. The mouse was introduced into the maze as before and
allowed to search for the missing platform for 60 sec. The maze
surface was logically partitioned into quadrants for analysis, and
the percentage of time that the mouse spent searching in each
quadrant was calculated. This percentage was used as an index of
memory performance, the logic being that if the mouse
remembered where the platform was during training, it would
spend a disproportionate percentage of its swimming time during
the probe trial searching in the quadrant where the platform was
located during the learning trials. Statistical analyses were
conducted using PRISM4 (GraphPad Software Inc., CA). Data
were analyzed using the Friedman test or repeated measures two-
way ANOVA, unless noted otherwise.
Novel object recognition test
The NOR task is based on the innate tendency of rodents to
differentially explore novel objects over familiar ones [23,47].
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session separated by 3 weeks; they were serially presented with new
object sets. In this scheme, each mouse is considered to be a naive
subject, and each performance is considered to be an independent
observation [50].
Saline- or PTX-treated adult nonTg and adult APP/PS1 mice
were given an opportunity to habituate to a new cage
(17 cm628 cm612 cm). After 15 min in this cage, mice were
exposed to two identical objects during a 15-min training session.
Objects were made from either metal or plastic (LEGO blocks)
and had various color schemes. Four groups of mice were tested
with these objects pseudo-randomly to make sure that, within an
experiment, each group of mice was tested with the same type of
object. The pairings of objects are shown in Figure S1. All objects
were generally consistent in height and volume. They were
positioned in two corners of the experimental field (Figure S1). A
15-min testing session was conducted right after training. Here,
the mice were presented with two objects—the object they had
explored in the training session and a new object. Novel object
recognition memory was operationally defined as the proportion
of time animals spent investigating the novel object (or an identical
object presented during the training session) and measured in
terms of a Preference Index (P. I.=(Novel Object Exploration
Time/Total Exploration Time)6100), where exploration consti-
tuted any investigative behavior (i.e., head orientation, sniffing) or
deliberate contact that occurred with each object. To control for
odor cues, the experimental cage was changed for each mouse,
and the objects were thoroughly cleaned with 90% ethanol, dried,
and ventilated for a few minutes between mice.
In Vitro fEPSP Recordings
Hippocampal slices (350 mm thick; horizontally sectioned) were
prepared in ice-cold aCSF (in mM, 124 NaCl; 2.5 KCl; 2 CaCl2;2
MgSO4; 1.25 NaH2PO4; 26 NaHCO3; and 10 glucose) contin-
uously bubbled with 95% O2/5% CO2. Slices were allowed to
recover in aCSF at room temperature for .1 hour prior to
recording, after which they were maintained at 29–30uC in the
same oxygenated conditions. Baseline responses were obtained
every 10 sec, and 3–6 responses were averaged to obtain a data
point. Stimulation intensity was subsequently set to a level that
produced a fEPSP slope value of about 40% of the maximum
obtained. LTP was induced by delivering a single train of tetani
(100 stimuli, 100 Hz) through a bipolar tungsten electrode
positioned in the molecular layer of the dentate gyrus. Field
potential recordings were obtained with borosilicate glass
capillaries filled with 0.5 M NaCl (0.3–0.5 MV) situated in the
dentate gyrus molecular layer. Slices were bathed in aCSF with or
without 20 mM bicuculline.
Western Blotting
Mouse brains were homogenized in Tris-buffered saline (TBS;
10 mM Tris, 150 mM NaCl [pH 7.4]) containing protease
inhibitors (1 mg/ml antipine, 5 mg/ml pepstatin, 5 mg/ml leupep-
tin, 2 mg/ml aprotinin, and 0.5 mM 4-(2-aminoethyl)benzenesul-
fonyl fluoride hydrochloride). After centrifugation at 100,000g for
20 min at 4uC, the supernatant was collected. The resulting
precipitate was re-homogenized in 3 volumes of modified RIPA
buffer (50 mM Tris [pH 7.4], 1% NP-40, 0.25% Sodium
deoxycholate, 150 mM NaCl, and 1 mM EGTA) and centrifuged
at 100,000g for 20 min at 4uC. The supernatant was analyzed as
the ‘‘membrane protein’’ fraction. After measuring and normal-
izing the total protein concentration by the Bradford method,
samples from this fraction were solubilized in Laemmli sample
buffer and subjected to SDS-PAGE. Separated proteins were
blotted onto a nitrocellulose membrane. The membrane was
incubated with the primary antibody followed by HRP-conjugated
secondary antibody. Chemiluminescent detection (ECL, Amer-
sham) was used for visualization. The primary antibodies used
were anti-GABAA receptor a1 subunit (Sigma); GluR1 (Chemi-
con); GluR2 (Chemicon); PSD95 (BD Transduction); NR2A (BD
Transduction); NR2B (BD Transduction); and phospho-Tyr1472
NR2B (Chemicon). Quantitation and visual analysis of immuno-
reactivity were performed with a computer-linked LAS-3000 Bio-
Imaging Analyzer System (Fujifilm).
Supporting Information
Figure S1 Type, pair, and position of objects during novel object
recognition (NOR) tests. (A) Four types of metal objects
characterized by their shape were paired as shown for the testing
session of the first set of NOR tests. The position of a novel object
is indicated by the letter X or Y, which corresponds to the corner
of the experimental field as shown in the schematic diagram
showing a bird’s eye view of the test apparatus. Six animals from
each group of the drug-treatment experiment were subjected to
the six different experimental schemes (Figure 4). (B) For the
second set of NOR tests, four types of objects were made from
LEGO blocks. Each object was characterized by a combination of
two colors and by different shapes. Objects used for the
experimental scheme in (A) were replaced with the LEGO objects.
Found at: doi:10.1371/journal.pone.0003029.s001 (1.73 MB TIF)
Figure S2 Effect of PTX treatment on the anxiety levels of
mice: novel object exploration (NOE). Avoidance of objects
placed in a familiar field is considered as a measure of anxiety
level [1]. The anxiety level of a mouse was estimated by
measuring the avoidance of two novel and two identical objects
placed into a familiar environment during the training session of
the novel object recognition (NOR) test. Thus, mice used in this
NOE experiment are the same cohort used in the NOR test
(saline-treated nonTg, saline-treated APP/PS1, PTX-treated
nonTg, and PTX-treated APP/PS1). The experimental field
was divided into three areas, as schematically represented in
Figure S1. The ‘‘objects field’’ represents the area located between
the left wall and 2.5 cm just left to the midpoint line. The ‘‘center
field’’ represents the area located between 2.5 cm left and just
right to the midpoint line. The ‘‘objectless field’’ represents the
rest of the experimental field. During the habituation and training
sessions, the number of entries into the objects field was counted
each time a mouse in the objectless field enters into the objects
field by passing through the center field. Thus, to be counted as
one entry, a mouse had to move to the objectless field and then
enter into the objects field. This calculation scheme was used to
avoid counting ambiguous entries. The number of entries during
the last 5 min of the habituation session was taken as baseline.
The number of entries during the first 5 min of the training
session relative to baseline was calculated in order to correct for
possible preferences for a particular field. In nonTg mice, PTX-
treated group on average showed less preference or more
avoidance of the objects field during the training session than
the habituation session whereas saline-treated group showed more
preference for the objects field although a statistical significance of
neither tendency was supported by binomial analysis (p=0.0537
for the avoidance of the objects field by PTX-treated nonTg mice
and p=0.2256 for the preference of the objects field by saline-
treated nonTg mice). In APP/PS1 mice, such a tendency to avoid
the objects field was not observed in PTX-treated group.
The dotted horizontal line represents chance performance. Data
are presented as means with error bars denoting S.E.M.
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